中国のトップリンパ腫医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
5
中国
レビュー
14000+
実際の患者より
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
盧佩華博士は、米国および中国の両国でライセンスを取得した血液腫瘍内科の専門家であり、細胞免疫療法の先駆者です。北京医科大学を卒業後、米国で研鑽を積み、スタンフォード大学にて臨床フェローシップを修了、その後、米国国立衛生研究所（NIH）より二つの権威ある賞を受賞しました。中国における腫瘍浸潤リンパ球（CIK）細胞療法の最初の導入者の一人でもあります。2015年に帰国後は、CAR-T療法および血液がん治療の発展を牽引してきました。盧博士は、中国非公立医療機関協会血液病委員会委員長を含む10以上の医療関連組織において指導的役割を担っています。また、「医療管理賞」や「年間最優秀人民医師」など、国家レベルの表彰も受けています。
診療科：血液内科・リンパ腫＆骨髄腫センター
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Chinaの22名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか？
治療をガイド
医療訓練を受けた専属コーディネーター
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|
China offers advanced lymphoma treatments including CAR T-cell therapy, hematopoietic stem cell transplantation (HSCT), and targeted immunotherapy. Facilities like Lu Daopei Hematology Hospital and Fuda Cancer Hospital follow national protocols. These centers integrate traditional chemotherapy with innovative cellular therapies for relapsed or refractory cases.
Bookimed Expert Insight: Data suggests Beijing is the primary hub for complex hematology. Lu Daopei Hematology Hospital operates 1,300 beds and 30 specialized departments. This massive scale allows for high-volume expertise in stem cell transplants. Patients seeking CAR T-cell therapy can find comprehensive packages at Beijing GoBroad Boren Hospital. These packages often include 30-day hospitalizations to ensure rigorous post-infusion monitoring.
Patient Consensus: Patients note that major Chinese cities offer faster enrollment in clinical trials for relapsed cases. They emphasize that while costs are lower, navigating logistics requires professional support due to language barriers.
Top Chinese hospitals for lymphoma care include JCI-accredited facilities like Fuda Cancer Hospital and specialized hematology centers such as Lu Daopei. These institutions provide advanced CAR-T cell therapy and hematopoietic stem cell transplantation. They serve thousands of international patients with specialized oncology protocols.
Bookimed Expert Insight: While many general hospitals treat lymphoma, specialty centers like Lu Daopei or Boren offer focused hematology infrastructure with 300+ expert doctors. Boren Hospital offers CAR-T therapy packages around $100,000. These include 30 hospital days and extensive diagnostics like biopsies and PET-CT scans.
Patient Consensus: Patients emphasize the need for a bilingual medical liaison to navigate top-tier centers. Many suggest combining local treatment with remote Western second opinions to ensure personalized care protocols.
Lymphoma treatment in China achieves high success at elite centers. Remission rates for Hodgkin lymphoma reach 90% in top-tier facilities. Leading hospitals report success matching global benchmarks for early-stage cases. Advanced therapies like CAR T-cell therapy provide durable responses for aggressive subtypes.
Bookimed Expert Insight: China's top hematology centers offer a massive volume of complex cases. Lu Daopei Hematology Hospital treats 200,000 patients every year. This high patient volume often leads to greater clinical proficiency. Patients can access CAR-T therapy packages at GoBroad Boren Hospital for approximately $100,000. These comprehensive packages include 30 hospital nights and extensive diagnostic testing.
Patient Consensus: Patients note that top-tier hospitals deliver results comparable to Western standards. They emphasize that early detection is vital for the best long-term outcomes.
Traditional Chinese Medicine (TCM) plays a supportive role alongside Western protocols in 90% of Chinese hospitals. It manages chemotherapy side effects like nausea and fatigue for lymphoma patients. Experts use acupuncture and herbal formulas to maintain the body internal balance during intensive treatments.
Bookimed Expert Insight: While TCM is culturally significant, China is currently a global leader in high-tech cellular therapies. Hospitals like Beijing GoBroad Boren Hospital focus heavily on CAR T-cell therapy for lymphoma. This indicates that patients seeking advanced cures should prioritize these specialized hematology centers first. They can then use TCM as a secondary tool for recovery and symptom management.
Patient Consensus: Patients value how TCM helps them feel more balanced during harsh treatments. They note that herbal therapies often make recovery periods between chemotherapy cycles feel more manageable.
Clarify diagnostic accuracy by asking if centers like Fuda Cancer Hospital utilize Joint Commission International (JCI) standards for pathology. Verify if doctors like Dr. Hu Kai perform CAR T-cell therapy under National Medical Products Administration (NMPA) approval. Inquire about exact hospital stay requirements and follow-up protocols.
Bookimed Expert Insight: Lymphoma packages in China, such as those at Beijing GoBroad Boren Hospital, often include 30-day hospitalizations for CAR T-cell therapy. This extended stay is much longer than standard international packages. Patients should confirm if this intensive monitoring is included in the initial $100,000 price or billed separately.
Patient Consensus: Patients emphasize the need for a Mandarin-speaking advocate or an effective translation app like WeChat. They also recommend bringing original pathology slides from home for a second review before starting intensive therapy.
Lymphoma treatment in China requires a stay of 3 to 12 weeks per cycle. Standard chemotherapy often lasts 3 to 6 weeks for monitoring. Advanced CAR-T cell therapy typically necessitates 8 to 12 weeks. This includes preparation, cell manufacturing, and intensive inpatient recovery.
Bookimed Expert Insight: Patients choosing Beijing GoBroad Boren Hospital for CAR-T therapy can expect highly integrated care. Their standard $100,000 package includes a full 30-day hospital stay. This ensures constant monitoring for cytokine release syndrome by specialists like Dr. Hu Kai. This long-term inpatient focus is unique compared to other regions where monitoring is often outpatient.
Patient Consensus: Patients note that arranging a long-term medical visa before arrival is vital. Many advise packing for extended hospital stays as observation periods can unexpectedly increase due to monitoring needs.